Safety of Xeloda in Solid Tumours

NCT02479217 · clinicaltrials.gov ↗

COMPLETED

Status

1268

Enrollment

INDUSTRY

Sponsor class

Conditions

Metastatic Breast Cancer, Colon Cancer

Interventions

DRUG: Docetaxel
DRUG: Xeloda

Sponsor

Hoffmann-La Roche